SCHEMBL25635477

SCHEMBL25635477

Cc1ccc2c(c1)c1cccc3c4ccccc4n4c5ccccc5c5cccc(c6ccccc6n2c31)c54

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALKBH5 Q6P6C2 1/20 0.46
FTO Q9C0B1 1/20 0.46
MAPT P10636 9/20 0.43
LMNA P02545 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
BCHE P06276 1/20 0.42
ACHE P22303 1/20 0.42
MEN1 O00255 6/20 0.41
KMT2A Q03164 6/20 0.41
KDM4E B2RXH2 6/20 0.41
HTT P42858 5/20 0.41
ALDH1A1 P00352 4/20 0.41
HPGD P15428 4/20 0.41
POLB P06746 1/20 0.41
PGR P06401 1/20 0.41
RORA P35398 1/20 0.41
RORC P51449 1/20 0.41
RORB Q92753 1/20 0.41
GPR3 P46089 1/20 0.39
TDP1 Q9NUW8 4/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10153568 1.00 ALKBH5 (0.46) ALKBH5FTOMAPTLMNASMN1; SMN2
SCHEMBL25635001 0.98 ALKBH5 (0.44) ALKBH5FTOMAPTLMNASMN1; SMN2
SCHEMBL24390065 0.95 ALKBH5 (0.44) ALKBH5FTOMAPTLMNASMN1; SMN2
SCHEMBL17265046 0.94 MAPT (0.47) ALKBH5FTOMAPTLMNASMN1; SMN2
SCHEMBL29322584 0.93 ALKBH5 (0.41) ALKBH5FTOMAPTLMNASMN1; SMN2
SCHEMBL17265054 0.93 BCHE (0.42) ALKBH5FTOMAPTLMNASMN1; SMN2
SCHEMBL25634963 0.93 BCHE (0.42) ALKBH5FTOMAPTLMNASMN1; SMN2
SCHEMBL24390061 0.91 BCHE (0.41) ALKBH5FTOMAPTLMNASMN1; SMN2
SCHEMBL25880169 0.91 MAPT (0.44) ALKBH5FTOMAPTLMNASMN1; SMN2
SCHEMBL16621615 0.89 ALKBH5 (0.46) ALKBH5FTOMAPTLMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230192714-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2023-06-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230192714-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES OCIAD2, OCIAD1, ODC1 ALKBH5 604/4885FTO 39/4885MAPT 1568/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.